Literature DB >> 3172683

[Dose response relations of allopurinol].

D P Mertz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3172683     DOI： 10.1007/bf01726419

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  8 in total

1.  The use and abuse of allopurinol in renal failure, the tumour lysis syndrome and HGPRT deficiency.

Authors:  J S Cameron; H A Simmonds; G S Morris
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

2.  Renal clearance of oxipurinol, the chief metabolite of allopurinol.

Authors:  G B Elion; T F Yü; A B Gutman; G H Hitchings
Journal:  Am J Med       Date:  1968-07       Impact factor: 4.965

3.  Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.

Authors:  G B Elion; A Kovensky; G H Hitchings
Journal:  Biochem Pharmacol       Date:  1966-07       Impact factor: 5.858

4.  [On the dose-effect relation of allopurinol (author's transl)].

Authors:  D P Mertz
Journal:  Arzneimittelforschung       Date:  1977

5.  Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.

Authors:  K R Hande; R M Noone; W J Stone
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

6.  [Uric-acid reduction with high allopurinol dosages (author's transl)].

Authors:  D P Mertz; H Loewer
Journal:  Dtsch Med Wochenschr       Date:  1979-03-02       Impact factor: 0.628

7.  The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality.

Authors:  J Z Singer; S L Wallace
Journal:  Arthritis Rheum       Date:  1986-01

8.  A study of dose-response relationships of allopurinol in the presence of low or high purine turnover.

Authors:  W Löffler; W Gröbner
Journal:  Klin Wochenschr       Date:  1988-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.